For instance, some research found that miR-142-5p regulates the expression of the proteins PD-L1 and PTEN in CD4+ T cells in NSCLC, which raises the possibility that miR-142-5p could be a potential target for NSCLC treatment (30). The gene discussed is PTEN; the disease is non-small cell lung carcinoma.